It's cost Botanix at least $20 million just to extinguish the royalties for Sofdra ( the obligations to fresh tracks were extinguished) and the cost of the last 3 cap raises. I'd rather they proved the Sofdra sales for 1 to 2 years before spending similar amounts on buying other I.P as I'd assume they would cap raise again rather than use profits as that suits themselves and the funds. I'm over the dilution now.
BOT Price at posting:
39.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)